Nicorandil versus isosorbide dinitrate as adjunctive treatment to direct balloon angioplasty in acute myocardial infarction

Heart

Volumn 90, Issue 2, 2004, Pages 181-185

  Ikeda, N ^a   Yasu, T ^a   Kubo, N ^a   Hashimoto, S ^a   Tsuruya, Y ^a   Fujii, M ^a   Kawakami, M ^a   Saito, M ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ISOSORBIDE DINITRATE; NICORANDIL; NITRIC OXIDE DONOR;

ACUTE HEART INFARCTION; ADD ON THERAPY; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY; DOUBLE BLIND PROCEDURE; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE WALL; HEART MUSCLE REPERFUSION; HEART VENTRICLE SEPTUM RUPTURE; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION;

EID: 0742307473     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2003.013789     Document Type: Article

References (38)

1. Schofer J, Montz R, Mathey DG. Scintigraphic evidence of the "no reflow" phenomenon in human beings after coronary thrombolysis. J Am Coll Cardiol 1985;5:593-8.
2. Ito H, Tomooka T, Sakai N, et al. Lack of myocardial perfusion immediately after successful thrombolysis: a predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992;85:1699-705.
3. Ragosta M, Camarano G, Kaul S, et al. Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction: new insights using myocardial contrast echocardiography. Circulation 1994;89:2562-9.
4. Anon. Effect of nicorandil on coronary events in patients with stable angina: the impact of nicorandil in angina (IONA) randomized trial. The IONA study group. Lancer 2002;359:1269-75.
5. Auchampoch JA, Cavero I, Gross GJ. Nicorandil attenuates myocardial dysfunction associated with transient ischemia by opening ATP-dependent potassium channels. J Cardiovasc Pharmacol 1992;20:765-71.
6. Mizumura T, Nithipotikom K, Gross GJ. Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog. Cardiovasc Res 1995;29:482-9.
7. Klein HH, Pich S, Lindert-Heimberg S, et al. Comparative study on the effects of intracoronary nicorandil and nitroglycerin in ischemic, reperfused porcine hearts. Eur Heart J 1995;16:603-9.
8. Galie N, Guarnieri C, Ussia GP, et al. Limitation of myocardial infarct size by nicorandil after sustained ischemia in pigs. J Cardiovasc Pharmacol 1995;26:477-84.
9. Gross GJ, Pieper GM, Farber NE. Effects of nicorandil on coronary circulation and myocardial ischemia. Am J Cardiol 1989;63:11J-7J.
10. Pieper GM, Gross GJ. Anti-free radical and neutrophil-modulating properties of the nitrovasodilator, nicorandil. Cardiovasc Drugs Ther 1992;2:225-32.
11. Yasu T, Ikeda N, Ishizuka N, et al. Nicorandil and leukocyte activation. J Cardiovasc Pharmacol 2002;40:684-92.
12. + channels. Am J Physiol 1996;270:H1744-56.
13. Kosonen O, Kankaanranta H, Malo-Ranta U, et al. Nitric oxide-releasing compounds inhibit neutrophil adhesion to endothelial cells. Eur J Pharmacol 1999;382:111-7.
14. Leesar MA, Staddard MF, Dawn B, et al. Delayed preconditioning-mimetic action of nitroglycerin in patients undergoing coronary angioplasty. Circulation 2001;103:2935-41.
15. Ito H, Taniyama Y, Iwakura K, et al. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol 1999;33:654-60.
16. Sakata Y, Kodama K, Komamura K, et al. Salutary effect of adjunctive intracoronary nicorandil administration on restoration of myocardial blood flow and functional improvement in patients with acute myocardial infarction. Am Heart J 1997;133:616-21.
17. Kobayashi Y, Goto Y, Daikoku S, et al. Cardioprotective effect of intravenous nicorandil in patients with successful reperfusion for acute myocardial infarction. Jpn Circ J 1998;62:183-9.
18. Kempsford RD, Hawgood BJ. Assessment of the antiarrhythmic activity of nicorandil during myocardial ischemia and reperfusion. Eur J Pharmacol 1989;163:61-8.
19. Kobayashi N, Ohmura N, Nakada I, et al. Further ST elevation at reperfusion by direct percutaneous transluminal coronary angioplasty predicts poor recovery of left ventricular systolic function in anterior wall AMI. Am J Cardiol 1997;79:862-6.
20. Rentrop KP, Cohen M, Blanke H, et al. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985;5:587-92.
21. Sheehan FH, Bolson EL, Dodge HT, et al. Advantages and applications of the centerline method far characterizing regional ventricular function. Circulation 1986,74:293-305.
22. Kubo N, Ohmura N, Nakada I, et al. Exercise training induces left ventricular enlargement in patients with left ventricular dysfunction. Circulation 1997;96:1345.
23. Iwakura K, Ito H, Takiuchi S, et al. Alternation in the coronary blood flow velocity pattern in patients with no reflow and reperfused acute myocardial infarction. Circulation 1996;94:1269-75.
24. Montalescot G, Barragan P, Wittenberg O, et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting far acute myocardial infarction. N Engl J Med 2001;344:1895-903.
25. Stane GW, Grines CL, Cox DA, et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 2002;346:957-66.
26. Farber NE, Pieper GM, Gross GJ. Postischemic recovery in the stunned myocardium after reperfusion in the presence or absence of a flow-limiting coronary artery stenosis. Am Heart J 1988;116:407-20.
27. Stahl ID, Aversano TR, Becker LC. Selective enhancement of function of stunned myocardium by increased flow. Circulation 1986;74:843-51.
28. Agati L, Voci P, Bilotta F, et al. Influence of residual perfusion within the infarct zone on the natural history of left ventricular dysfunction after acute myocardial infarction: a myocardial contrast echocardiographic study. J Am Coll Cardiol 1994;24:336-42.
29. Camarano G, Ragosta M, Gimple LW, et al. Identification of viable myocardium with contrast echocardiography in patients with poor left ventricular systolic function caused by recent or remote myocardial infarction. Am J Cardiol 1995;75:215-9.
30. Komaru T, Lamping KG, Eastham CL, et al. Roles of ATP-sensitive potassium channels in coronary microvascular autoregulatory responses. Circ Res 1991;69:1146-51.
31. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 1995;268:C799-822.
32. + channel openers, a class of drugs with vasorelaxant and cardioprotective properties. Life Sci 1990;47:1693-705.
33. Maruyamo M, Farber N, Gross GJ. Effect of the new potassium channel opener EMD 52892 on coronary collateral blood flow in dogs. FASEB J 1989;3:A897.
34. Romson JL, Hook BG, Kunkel SL, et al. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 1983;67:1016-23.
35. Hansen PR. Role of neutrophils in myocardial ischemia and reperfusion. Circulation 1995;91:1872-85.
36. Fukuda S, Yasu T, Predescu DN, et al. Mechanism far regulation of fluid shear stress response in circulating leukocytes. Circ Res 2000;86:E13-8.
37. Miki T, Suzuki M, Shibasaki T, et al. Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir 6.1. Nat Med 2002;8:466-72.
38. ATP channels. J Clin Invest 2002;110:203-8.